Jones Financial Companies
ATOS icon

Jones Financial Companies’s Atossa Therapeutics ATOS Stock Holding History

Jones Financial Companies’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.73K Buy
2,061
+2,014
+4,285% +$12.8K ﹤0.01% 3589
2025
Q4 		$413 Hold
47
– – ﹤0.01% 4191
2025
Q3 		$601 Hold
47
– – ﹤0.01% 4003
2025
Q2 		$615 Hold
47
– – ﹤0.01% 3769
2025
Q1 		$487 Buy
+47
New +$571 ﹤0.01% 3512

Other funds holding ATOS

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jones Financial Companies's ATOS Position: Q1 2026 in Review

Jones Financial Companies increased its Atossa Therapeutics (ATOS) stake by 4,285% in Q1 2026, buying an estimated $12.8K and bringing the position to 2,061 shares worth $9.73K. The position accounts for ﹤0.01% of the portfolio, ranked #3589.

Jones Financial Companies first reported a position in ATOS in Q1 2025 and has held it in 5 quarters since. 33 funds tracked by Wall St. Rank hold ATOS as of Q1 2026.

  • Jones Financial Companies held 2,061 shares of Atossa Therapeutics worth $9.73K as of Q1 2026.
  • Jones Financial Companies bought 2,014 Atossa Therapeutics shares in Q1 2026, an estimated $12.8K.
  • Atossa Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3589 holding.
  • Jones Financial Companies first reported a position in Atossa Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 33 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.